Century Pharma is a 30-year-old pharmaceutical company based in Gujarat, India that manufactures active pharmaceutical ingredients and engages in biotechnology research. The company was founded in 1982 and is led by CEO Janak Sheth. Century Pharma produces APIs, engages in contract manufacturing and research, and method development. The company is working to develop treatments for conditions like asthma through biotechnology and stem cell research.

1. CENTURY
PHARMA
A THIRTY YEARS OLD TRUSTED NAME IN THE
PHARMACEUTICAL WORLD
Mr. Janak Sheth
CEO
BEST
INNOVATIVE
PHARMACEUTICALS
FIRM 2020
www.businessshouts.com

2. JANAK SHETH
BLOGS
INTERVIEW
The Future of
Biopharmaceutical
Industry
Challenges facing
Pharma
Industries
Mr.ABHINAV THAKUR
MD at Accurex
CEO
CO
NT
Cover Story
7
22
11

3. Dr.SHRINIVAS SHINDE
Physiotherapist
Dr.GAURAV CHANDOLKAR
Orthopaedic Physiotherapist
EN
TS
CEO Founder
Cofounder (CEO)
16
19

4. Editorial in Chief
Managing Editor
Senior Editor
Project Manager
Sales Head
Business Development Executive
Art Director
Visualiser
Graphic Designer
Head of Distribution and Productions
Head of Operation
Research Analysis
Swapna D.
Arnav Singh
Pranali Sarkar
Steve D’cruz
Sophia Smeeth
Vicky Patil
Sweety Pande
Jennifer Margaret
Varsha Srivastav
Vivek Shastri
Jacob M.
Kalpana P.
2020-2021
We are available on:
www.instagram.com/businessshouts_/
www.linkedin.com/company/businessshouts-media-technology/
Follow us on:
Emial:
businessshouts.official@gmail.com
People behind this issue
www.twitter.com/businessshouts_
www.facebook.com/businessshoutsmedia

7. P al history of India and the rest of the
world traces its roots back to Gupta Period circa
400 CE in mediev t civiliza
like Chinese, Indus Mediterranean where tr
methods were employed to treat ailments and other
purposes. However, the modern shape of the
al Industry is due to the developments
caused by the Industrial Rev
as a source of raw materials for the
industry, products were manufactured in the foreign
na ere exported back to India again. The first
al industry, Bengal Chemical was
established in the early 20th cen a. At the
near end of 20th century, Indian scien ts like P C Ray, T
K Gajjr, and A S K ar laid the founda or the
al industry in India. Amidst this
Shazam, the founda tury Pharma was laid in
the district Panchmahal, Gujarat 1982 with a purpose of
manuf al Ingredients.
Today al Industry ranks third in
the world in volume and 14th in terms of value. The real

8. growth was experienced only a er the embracement of
Neo-liberal reforms introduced in the last decade of the
20th century. With corporate office and Headquarters in
Vadodara, Gujarat, the firm is led by a chemical
engineer, Dr. Janak Sheth, an alumnus of IIT Delhi and
the managing director of the firm. The firm offers
various kinds of ser o the
manuf als Ingredients
undertaking long-term contracts for producing
intermediates and development of ne e
al Ingredients as per the industry
requirements. The firm pays a strong emphasis on
rendering value added services to its customers at a
reasonable cost. Cen als Limited
manufactures and dev al
Ingredients in their own Research and Development
facility. The firm is a 100 people strong family-owned
firm and atpresent a closely held public limited
company. Their factory is located in Halol near
Vadodara.
Our editorial team spoke to Mr. Janak Sheth, Owner
manager of Century Pharma and CEO of the
Biotechnology research. Mr. Janak is an Industry
veter al world with a total
experience of 42+ years. He had a s t of an
interna t to execute a greenfield
al project before st
Products, Services and Differen actors
Century is a customer-focused organiza
primarily involved with the manufacturing of API
Products at ' reasonable prices. API Research,
Animal Health, Biotechnology, Contract
Manufacturing, Contract Research, Method
Development, and Stability Studies are the
other products and services rendered by
Century Pharma. Their major revenues come mainly
fr e ingredients to the
al finished product manufacturers.
Steps in biotechnology domain
The firm has not limited itself to the manufacturing of
API products but has recognized the poten
Biot al Industry and
enhancing the specificity and eff eness of drugs,
improvement of lifestyle quality and working on the
unmet needs of the Industry. The firm is involved with
the crea ant biotechnology research
c ea of targeted human ther
proteins. Currently, the firm's R & D department is also
involved in developing more API products. The firm
jointly developed a Biotech drug discovery Research and
Development program with an Israeli partner to develop
Recombinant fusion proteins for the treatment and cure

9. of As
the preclinical ar
and have undertak
s
government. The
supplying resear
cost-eff
Cen
undertaking contr
development of R
biotechnology c
stem cell resear
Clients and Rivals
Their client lis
over mor
MSME units. The
ingredien
customers operat
other coun
o Drugs, FDC,
to
yers
ce their
al compe ors of
oducts
e
er emissions
. Century
t and have
e
or Fair
S,
thma and Mastocytosis. They are also working in
ea, established the proof of concept
en toxicology studies and animal
tudies while in the process of filing NBE with the Indian
yundertook the responsibility of
ch grade biotechnology products in a
e manner with assured confiden .
tury Pharma's interest domain extends to
act resear al
ecombinant proteins for
ompanies. They are also engaged in
ch and its clinical trials.
t of more than 750 customers expands
e than 60 countries and include pres
e Pfizer eva
ge corporates like Cipla, Zydus
Cadila, Macleods, and Glenmark as well as various
y ar als
ts since last 4 decades. Some of their major
e in India and export their products to
tries. Our customers like Cadila
als, Lincoln Pharma, Heter
Wallace Pharma, Int als, Aris
als, JB Chemicals and other Indian pla
al industry regularly sour
APIs from Century. Century have sever
various sizes in this field, but they take them as
o improve the quality of their pr
and services while maintaining their mark
The Milestones and Rec
The firm has been earning profits con
ompany has a green concept by making
investments for a green future with low
while genera enewable solar electricity
have a WHO GMP quality manufacturing plan
successfully achieved a pres
industry. Other honorable accolades ar
*Fair Business Pr
Businesses)
• Gold Medal for excellence in Business Pr
(Switzerland)
• Excellence for Innova , Pr
India)

10. • Gold Award fr ech
technology
• FGI award for excellence "outstanding MSME" -2011
Leaders of tomorrow by ET NOW — October 2013
• Conferr ate of Excellence for smart
innova esponsible business in a leading business
Magazine —January 2015 Quality Mark Trust Award —
May 2015 Century Pharma selected as fastest growing
al Company of 2016 in a leading business
magazine Winner of Quality Mark Trust Awards 2016
at a om QCI India
company by Dun and Bradstreet Excellence for
Innova , Pr , Management (IES,
India) ISO 9001 for many years. ISO 14000 and EHS
systems.
The Road Ahead
On the future road, Century hopes to find a remedy for
asthma and allergies and the future of medicines
through stem cell therapies for various ailments.
Century is also working on a personalised cancer
treatment with a targeted therapy technology.
Currently, they are looking for a strategic partners to
work with them for comple esearch
for asthma and look for out-licensing the technology
once they get a e valua y hope that the
government approves stem cell therapies as an
alterna e therapy soon and hence they could
commercialise their research and benefit from it. On
Century's revenue model, they hope to reach Rs 500
crores in five years from today.
The company is looking forward to capitalizing the
opportunity created by Chinese companies who have
not c
down or reduced pr or
the company as several overseas customers have
approved Century as their approved source which will
bring good prospects for the company. Century is
expanding it's product and will start serving new
markets.
7

11. Mr.ABHINAV THAKUR
MD at Accurex

12. In an interview with BusinessShouts, Mr. Abhinav
Thakur, the Managing Director of Accurex Biomedical
Pvt. Ltd with a means to diminish the hole between the
Indian diagnostic industry and the remainder of the
world.
Since its foundation in 1984 has utilized these
profoundly trends innovations with a mission Saving
Live Through
Quality Medical Diagnostic
Solutions.
Enhancing the Safety of Diagnostic
Lab Tests- Accurex
Please brief our audience about your company, its
values, vision, and mission.
In 1984 almost 100% of the diagnostic reagents were
imported into India. Mr. A.J. Thakur founded Accurex
in 1984 to indigenise the manufacturing of imported
reagents in India.
Accurex was the first company in India to manufacture
urine test strips and enzymatic clinical chemistry
reagents. This was the beginning of the IVD clinical
chemistry manufacturing industry of India.
The journey of Accurex since 1984 has been on a
growth trajectory. With the continuous launch of inno-
vative products Accurex has created a brand name in
the Indian IVD Industry.
Vision: To be one of the Top 3 world class Indian medi-
cal diagnostics companies that adds value to all its
stakeholders.
Mission: Saving Lives Through Quality Medical Diag-
nostic Solutions
Values: Honesty, Perseverance, Prosperity, and Innova-
tion.
What are the prominent services and products that
your company offers?
Accurex provides a plethora of innovative and trust-
worthy medical diagnostic solutions. In the laboratory
diagnostics space, Accurex offers the entire range of
clinical chemistry and hematology reagents. In instru-
ments, it offers semi-automated, fully automated
clinical chemistry, and 3 part & 5 part hematology
analyzers. The company also offers urinalysis test
strips, urinalysis meters, and immunology rapid tests.
Besides these, Accurex offers blood glucose meters,
hemoglobin meters, HbAlc meters, immunofluores-
cence meters, uric acid meters, and respective test
strips in the Point of Care (POC) segment. Moreover,
it has recently launched hand sanitizers, face masks,
face shields, infrared thermometers, viral transport
medium, and COVID-19 rapid antibody tests to fight
against the pandemic and fill the void caused by a drop
in sales of its routine products.

13. Brief us about the featured person(s) and their jour-
ney in the pharma industry.
The company operations are spearheaded by Abhinav
Thakur, Managing Director at Accurex Biomedical. He
graduated from the world-renowned University of Cali-
fornia-Davis before completing his PGDM at NMIMS
University, Mumbai. When he was studying in the
USA, unfortunately, his father died untimely at a young
age of 49, that led him to join the family business.
Since his appointment as the Managing Director, the
company has grown 4.2 times in revenue and the size of
the team also increased from 90 to 170 individuals.
Over the past decade, Accurex has grown from a diag-
nostic reagent company to a diagnostics reagents and
instruments company.
Being an experienced leader, what is your opinion
on the adaptation of newer technological develop-
ments to sustain business competency?
“It is very important to grow an organization to satisfy
the aspirations of all the stakeholders. Growth is like
what oxygen is for life. Growth is important to sustain
an organization,” Technological developments is
oxygen for a business. Without it the business will
cease to exist.
INNOVATE
BEST
PHARMACEUTICALS
FIRM 2020

14. Spine problems/Postural prob-
lems
The spine is our body’s central
support structure. It keeps us
upright and connects the different
parts of our skeleton to each other:
our head, chest, pelvis, shoulders,
arms and legs. Although the spine
is made up of a chain of bones, it
is flexible due to elastic ligaments
and spinal discs.
Because of lifestyle issues nowa-
days more than 80% of people
suffer from the back pain or lower
back pain. Posture is an important
part of your long-term health.
Making sure that you hold your
body the right way, whether you
are moving or still, can prevent
pain, injuries, and other health
problems.
Joint disorders
A joint is where two or more bones
come together, like the knee, hip,
elbow, or shoulder. Treatment of
joint problems depends on the
cause. If you have a sports injury,
treatment often begins with the
RICE (Rest, Ice, Compression, and
Elevation) method to relieve pain,
reduce swelling, and speed heal-
ing. Other possible treatments
include pain relievers, keeping the
injured area from moving, rehabil-
itation, and sometimes surgery.
Pre & Post Cardiac
Rehabilitation
Cardiac rehabilitation doesn’t
change your past, but it can help
you improve your heart’s future.
Cardiac rehab is a medically
supervised program designed to
improve your cardiovascular
health if you have experienced
heart attack, heart failure, angio-
plasty or heart surgery.
Post Fractures orthopedic/
traumatic rehabilitation
Physiotherapist After a fracture,
Physiotherapist may be ordered to
help ensure you return to optimum
function as quickly as possible.
You may encounter a physical
therapist at different times after
suffering a fracture.
Pulmonary Rehabilitation
Pulmonary rehabilitation is a
supervised program that includes
exercise training, health education,
and breathing techniques for
people who have certain chronic
lung conditions or respiratory
problems due to other conditions.
Neurological disorders
A neurological disorder is any
disorder of the nervous system.
Structural, biochemical or electri-
cal abnormalities in the brain,
spinal cord or other nerves can
result in a range of symptoms.
Geriatric and Women’s health
Geriatric physiotherapy treatment
offers prevention and intervention
measures to protect and enhance
their quality of life. Physiotherapy
for old people offers to improve
mobility & balance, build strength,
boost confidence in their physical
condition, boosts joint range, and
enhances strength & flexibility.
Women’s health physiotherapy,
she says, is all about ‘muscle
coordination’ and treating pelvic
floor muscles that have become
either underactive. Women’s
Health Physiotherapy refers to the
non-surgical therapeutic treatment
specific to various health problems
affecting women. During the
course of therapy, specially
designed exercises and equipment
are used to help patients restore
their normal physical activities.
The Physionic Clinic can possibly
change the lives of millions of
individuals over the globe to
improve things.
Taking into consideration, the
current pandemic, and its impact
on global economies, how are
you driving your organization to
sustain operations and
ensuring safety of your employ-
ees at the same time?
Adapting to the New Normal “As
an organization, we need to be agile
to adapt to the changes happening
in the external environment. As we
have seen in millions of years of
evolution that it’s the species that
adapt survives the longest and the
species that don’t adapt go extinct,”
asserts Abhinav. He believes that
businesses that innovate and adapt
to the changes caused by the pan-
demic will survive and some may
even prosper.
For instance, due to the pandemic,
Accurex has converted most of its
fixed costs into variable costs since
the top-line forecast was uncertain.
This helped the company maintain
the cash flow to sustain its opera-
tions. Consequently, by changing
its business model to cater to the
needs caused by the pandemic,
Accurex plans to sustain and over-
come the challenges caused by the
pandemic.
For the safety of our office employ-
ees in the COVID hotspot Mumbai
we will continue with work from
home until it's safe for employees
to travel to work.
Where do you envision your
organization to be in the long run
and what are your future goals?
In the next decade we want to
become the #1 Indian diagnostics
company.
Give us a few testimonials of your
clients that accurately highlight
your organization’s position in
the market.
On google we have 1,146 reviews.
This is the highest number of
reviews in our industry.
We are proud our google reviews
rating is 4.8/5. This validates our
high levels of customer service.

16. Dr.Shrinivas Shinde
Orthopaedic Physiotherapist
CEO Founder

17. Dr. Shrinivas Shinde is a known Orthopaedic
Physiotherapist and Chiropractor in Nanded and
has experience of more than 5 years . he has
completed his Bpth (Bachelor Of Physiotherapy)
from Krishna Institute of Medical Sciences
Deemed University, Karad, Maharashtra. After
which he completed his (Mpth) Master in Ortho-
paedic/Musculoskeletal under the roof of the same
Institute. Followed by his studies he has actively
participated in all the activities/research/medical
camps and has also Worked as resident in the
department of Orthopaedics for 2 years.
After which he went to Pune for his further studies
and practice. He worked as consultant physiother-
apist in The Physio9 Clinic at Viman Nagar &
Magarpatta, Pune. In the same year he completed
his DNS (Dynamic Neuromuscular Stabilization)
from Prague, Czech Republic. Then again joined
the Osteopathy Fellowship Programme in The
Physio9 Clinic under the guidance of one of the
senior and leading physiotherapists and chiroprac-
tor Dr. Mahesh Chakor.
Later on in the year of 2020 he wanted to give his
contribution to the society and opened his own
“Physionic Clinic” in the heart of Nanded, Maha-
rashtra.
The Physionic Clinic:
Improving Quality of Healthcare Era

18. Spine problems/Postural prob-
lems
The spine is our body’s central
support structure. It keeps us
upright and connects the different
parts of our skeleton to each other:
our head, chest, pelvis, shoulders,
arms and legs. Although the spine
is made up of a chain of bones, it
is flexible due to elastic ligaments
and spinal discs.
Because of lifestyle issues nowa-
days more than 80% of people
suffer from the back pain or lower
back pain. Posture is an important
part of your long-term health.
Making sure that you hold your
body the right way, whether you
are moving or still, can prevent
pain, injuries, and other health
problems.
Joint disorders
A joint is where two or more bones
come together, like the knee, hip,
elbow, or shoulder. Treatment of
joint problems depends on the
cause. If you have a sports injury,
treatment often begins with the
RICE (Rest, Ice, Compression, and
Elevation) method to relieve pain,
reduce swelling, and speed heal-
ing. Other possible treatments
include pain relievers, keeping the
injured area from moving, rehabil-
itation, and sometimes surgery.
Pre & Post Cardiac
Rehabilitation
Cardiac rehabilitation doesn’t
change your past, but it can help
you improve your heart’s future.
Cardiac rehab is a medically
supervised program designed to
improve your cardiovascular
health if you have experienced
heart attack, heart failure, angio-
plasty or heart surgery.
Post Fractures orthopedic/
traumatic rehabilitation
Physiotherapist After a fracture,
Physiotherapist may be ordered to
help ensure you return to optimum
function as quickly as possible.
You may encounter a physical
therapist at different times after
suffering a fracture.
Pulmonary Rehabilitation
Pulmonary rehabilitation is a
supervised program that includes
exercise training, health education,
and breathing techniques for
people who have certain chronic
lung conditions or respiratory
problems due to other conditions.
Neurological disorders
A neurological disorder is any
disorder of the nervous system.
Structural, biochemical or electri-
cal abnormalities in the brain,
spinal cord or other nerves can
result in a range of symptoms.
Geriatric and Women’s health
Geriatric physiotherapy treatment
offers prevention and intervention
measures to protect and enhance
their quality of life. Physiotherapy
for old people offers to improve
mobility & balance, build strength,
boost confidence in their physical
condition, boosts joint range, and
enhances strength & flexibility.
Women’s health physiotherapy,
she says, is all about ‘muscle
coordination’ and treating pelvic
floor muscles that have become
either underactive. Women’s
Health Physiotherapy refers to the
non-surgical therapeutic treatment
specific to various health problems
affecting women. During the
course of therapy, specially
designed exercises and equipment
are used to help patients restore
their normal physical activities.
The Physionic Clinic can possibly
change the lives of millions of
individuals over the globe to
improve things.

19. Dr. Gaurav Chandolkar
Physiotherapist
Cofounder (CEO)

20. Dr Gaurav Chandolkar is a renowned Cardiopulmo-
nary Physiotherapist in Nanded and has experience of
more than 5 years . He has completed his Bpth (Bachlor
Of Physiotherapy) from Krishna Institute of Medical
Sciences Deemed University, Karad, Maharashtra. After
which he completed his (Mpth) Master in Cardiopulmo-
nary/Cardiorspiratory Physiotherapy under the roof of
the same Institute. Following his studies he has actively
participated in all the activities/research/medical camps
and has also Worked as resident in the department of
CVTS (Cardiovascular and Thoracic Surgery) for 2
years.
After which he went to pune for his further studies
and practice. He worked as consultant physiotherapist in
The Physio9 clinic at viman Nagar & Magarpatta, Pune.
In the same year he completed his DNS (Dynamic Neu-
romuscular Stabilization) from Prague, Czech Republic.
Then again he joined for Osteopathy Fellowship
Programme in The Physio9 Clinic under the guidance of
one of the senior and leading physiotherapists and chiro-
practor Dr. Mahesh Chakor.

21. Matrix Rhythm Therapy
Matrix-Rhythm-Therapy is an innovative thera-
peutic approach at the core of modern 21st Cen-
tury medicine. It is german technology and based
on the cell regulation treatment that all cells of
biological systems oscillate rhythmically as long
as they are alive.
Chiropractic treatment
Complementary medicine based on the diagnosis
and manipulative treatment of misalignments of
the joints, especially those of the spinal column,
which are believed to cause other disorders by
affecting the nerves, muscles, and organs.
Osteopathy
An osteopath aims to restore the normal function
and stability of the joints to help the body heal
itself. They use their hands to treat your body in
a variety of ways, using a mixture of gentle and
forceful techniques.
DNS
DNS is a manual and rehabilitative approach to
optimize the movement system based upon the
primitive reflexes & scientific principles of
developmental kinesiology (DK).
Longwave Therapy
Long Wave Diathermy generally decreases pain,
increases metabolic functions, increases deep
tissue temperature and increases range of
motion.
Soon, “Physionic Clinic” will give more greater
advantages to a lot more patients with better
innovation and granular information on what is
successful.
Later on in the year 2020 he wanted to give his
contribution to the society and started his own
“Physionic Clinic” in the heart of Nanded,
Maharashtra.
Our aim is to deliver the best effective treatment
in the field of physiotherapy / Chiropractic /
Osteopathy / Dynamic Neuromuscular Stabiliza-
tion (DNS).
Chattanooga™ intelect mobile 2 combo
With the help of well prescribed exercises along
with best in class electrotherapy Chattanooga™
Intelect Mobile 2 Combo will help you to recov-
er from pain, return to function and maximise
performance.
INNOVATE
BEST
PHARMACEUTICALS
FIRM 2020

22. The Independent physical
association (IPA) stats that
there are few roadblocks
for
the Pharmaceutical indus-
try.
During this COVID- 19
pandemic period, pharma-
ceutical companies/ Indus-
tries are
facing a rapid challenges
which are arising from
disruption in supply chains
and that
leading to the change in the
business processes. If the
current situation
(COVID-19)
pandemic may for a medi-
um/long duration of time,
which might impact the
supply
of active material and
ingredients (mostly export-
ed from China), as well as
the
import and export of phar-
maceuticals.
There may be a high nega-
tive impacts for both short
and longer term on
Research
& Development and manu-
facturing processing, and
also a drastic delay on
projects/programmers not
related to the core supply
chain/data management
operations.
Challenges facing Pharma Industries
Lack of stable policy and
pricing.
With the local government
policies and terms to the
Pharmaceutical industry/
companies facing many
challenges in India that
have created an uncertain
environment for invest-
ments and innovations.
Independent physical
association
suggests that each and
every government as well
as stakeholders should
work
together to develop proper
plan to produce affordable
drugs for Indian patients
with
affable prices. New start
up industries didn't get
environmental clearance
from the
local governments this
leads to a major problem
for the local environment
and
sometimes leads to a
major damage in the
industry, as we see few
incidents happen
recently in India by not
following the basic rules
and that effect the major
loss.

23. Lack of capabilities in the innovation space
The resent report states that the governments
should invest in research &
development, initiatives and talent of the individual
in order to grow India’s
innovation. Insufficient trained and manpower for
operating reactors in Automation
mode for final API product. Clinical trials should
also be supported and subjectivity
in certain regulatory decision-making that should
not affect the environment and
should follow the terms of IPA.
External markets
India is majorly depending on other neighbor
countries for intermediates and active
pharmaceutical ingredients (APIs), with is closely
to 80 percent of the APIs used in
India fulfilled by China. Insufficient financial
budget in Indian pharmaceutical market
for critical reactions during production of costly
medicines. India should start
improving the infrastructure that can help in the
development of internal facilities
to stabilize supply and also to reduce the cost of
the medicine.
Quality compliance scrutiny
From a decade India has experienced the highest
number of FDA inspections and
also continued investment into upgrading quality
standards. This investment will
divert capital away from other areas of develop-
ment and distract from growth, says
the alliance.
Demand Forecasting
One of the biggest challenges companies in the
pharmaceutical industry face is to
devise reliable market forecasts and enhance the
customer service levels, which is
due to inefficient demand forecasting. Demand
forecasting is an essential
component for the pharma companies to stay ahead
in the competition and match
the supply on demand. Additionally, ensuring that
all the goods are produced at the
desired time and delivered seamlessly and poses a
big challenge to the pharma
companies. The inconsistency and errors in supply
process is a significant hurdle that
companies in the pharmaceutical industry are
facing.

24. The IPA highlight that “Indian pharmaceu-
tical companies need to take Clear moves
into uncharted territories.” In the report,
the association suggests some actionable
steps to encourage the growth of the
industry.
Establishing a Ministry of Pharmaceuticals
was suggested as an effective way to help
the Indian pharmaceutical industry grow.
This would be an independent body that
would enable better coordination and
faster decision-making.
A further suggestion is for the Indian phar-
maceutical industry to focus on API
manufacturing, so that there is less reliance
on imports into the country. This could
be completed several ways, including
constructing dedicated zones for the
manufacture of APIs.
The report further highlights a step already
being undertaken by the Indian
government to encourage industry growth.
In provinces such as Telangana State
and Uttar Pradesh, local governments have
announced their intention to build
‘pharma parks’, which will lend the indus-
try a competitive advantage. However,
more measures can be taken on the path
towards growth.
The impact of the global pandemic is still
unknown, pharma companies need to
respond, recover.
Conclusion
INNOVATE
BEST
PHARMACEUTICALS
FIRM 2020

25. COVID-19 pandemic is not just a
global health crisis, it is also a
hard-hitting financial crisis for
several economies. This unprece-
dented has been a hard time for the
manufacturing industries in
general, and highlighted the emer-
gency for India to become self-reli-
ant. Though the rhetoric of
‘Atmanirbhar Bharat’ gives some
hope of growth after a brief pause,
the ongoing pandemic has
affected the “self-reliant” agenda
quickly. The pandemic reiterated the
fact that India is dependent
on imports for much of the essential
medical equipment. The irregularities
in supplies not just
skyrocketed the domestic prices for
many of the medicines but it has also
disturbed foreign trade
because of the restrictions on exports.
The low presence of Key Starting
Material in our country has
highlighted the weak points of our
pharmaceutical sector.
Over the coming years, we expect
pharmaceutical industry models to be
reshaped by some forces
both from within and outside of the
industry- that will demand present
organisations to recognise
shifting markets and figure out how
they will compete in the changing
market. Biopharmaceutical
companies will continue to evolve in
new ways to treat and cure a variety
of diseases. However, in
future actionable health insights,
driven by artificial intelligence and
big data analytics, can help
doctors and patients to identify
illness much quicker than the time we
require today. In first place,
the newly invented vaccines and
other early interventions due to tech-
nological advancements could
prevent a greater number of illnesses
from developing. Other diseases can
be prevented through
other than pharmacological treat-
ments. Changes in how diseases are
recognised, prevented,
diagnosed, treated, or cured might
lead to basically different business
models for traditional
pharmaceutical companies.
The future of health that we will
witness in upcoming years will be a
much different from what we
have now. Based on evolving tech-
nologies, we can be much sure that
digital transformation driven
by big data analytics, artificial intelli-
gence and through such secure
platforms will be key in leading
this change. Unlike today, we can
expect that care will be streamlined
around the patients, rather
than around the institutions that drive
our current health care system.
In next few years, streams of health-
care data, combined with data from a
variety of other relevant
resources will probably merge to
create a multifaceted and highly
personalised picture of well-being
of every patients. Many digital health
organisations have already started to
incorporate biosensors
and software into devices that can
create, gather, and integrate data.
Advanced cognitive intensive
technologies can be developed to
analyse a precisely large set of
parameters and create personalised
insights into health of the patients.
The availability of streamlined data
and personalised AI can
enable much precise well-being and
actually real-time micro-interven-
tions that will allow us to get
ahead of illness and far ahead of cata-
strophic or chronic disease. By 2040,
health is much more
likely to revolve around preventing
some illnesses from happening, and
curing others. Many fewer
people might have long-term condi-
tions or chronic disabilities with
continued need for medicinal
needs to treat symptoms.
The few factors that may be the most
important components of shaping the
future of pharmaceutical
industry can be: Prevention or Rec-
ognition and early detection, Stream-
lined or customised
treatments, Curative therapies, Digi-
tal therapeutics, and Precision inter-
vention.
The Future of the Biopharmaceutical Industry

26. Prevention and early detection:
Vaccine and general improvements
in wellness could help
prevent illnesses, making treatment
for some illnesses no longer essen-
tial. Progress in early
detection will more likely enable
interventions that halt diseases in
the beginning stages before they
progress to become more serious or
chronic conditions.
Customized treatments: Person-
alised services in medicine driven
by data-powered insights can
effectively match patients with
customised drug medicines, or
design therapies that will work for
just a few number of people, or
even a specific person. The more
customised treatments will be the
most important part of the pharma-
ceutical industry in the future.
Curative therapies: As with
prevention, treatments that cure the
diseases can reduce or eliminate
the much demand for some
prescription medicines. Develop-
ing, marketing, and costing these
curative treatments may require the
pharma sector to adopt new capa-
bilities and strategies.
Digital therapeutics: Increasingly
effective, pragmatic and scalable
non-pharmaceutical (digital)
interventions or methods including
those focused on behaviour modifi-
cation can also reduce or
eliminate the demand for medica-
tions.
Precision intervention: Increas-
ingly urbane or evolved medical
technology such as precise or to
the point medical intervention
enabled by Big data analytics,
robotics, nanotechnology, AI or
tissue
engineering can reduce the need for
biopharmaceutical intervention.
As we move ahead the future of
health, biopharma starters should
consider new strategic or more
clever investments to set them-
selves for success. The changes that
we see in general will likely
require pharmaceutical companies
to think of new types of markets,
alternative creative business
models, or a major change in how
they precisely define what work
they do.
Modern medicine is nothing short
of miracles, especially in compari-
son to the medicine of even a
decade or more ago. But medicine
can always be much better, and the
pharmaceutical branch of the
healthcare industry plays a much
bigger role than ever in our every-
day lives and we all should
recognize it, appreciate it for
healthier lives and healthier contri-
bution to our families, societies,
nation and the world.

27. Business Shouts Media & Technoligy
info@businessshouts.com
Subscribe Us Read First!!
Name
Address
City
Date
State Zip
Telephone
Email
Country
Happy to Subscribe BusinessShouts Magazine
Worldwide Subscription
www.businessshouts.com

28. BEST
INNOVATE
PHARMACEUTICALS
FIRM 2020
CENTURY PHARMACEUTICAL LTD.